Drug delivery strategies for common orofacial diseases

Journal of Drug Targeting

Volumn 14, Issue 8, 2006, Pages 583-597

  Liu, Xin Ming ^a   Reinhardt, Richard A ^b   Wang, Dong ^a  

^a UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

^b UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

Author keywords

Bone targeting; Enzyme; On demand drug release; Oral cavity; pH sensitive; Tooth

Indexed keywords

ACICLOVIR; AMLEXANOX; ANALGESIC AGENT; ANTIINFECTIVE AGENT; ANTIVIRUS AGENT; ARESTIN; ATRIDOX; AZATHIOPRINE; BECLOMETASONE; BEHENYL ALCOHOL; BENZYDAMINE; BIFLUORIDE; CHLORHEXIDINE; CITRATE SODIUM; COPOLYMER; CORTICOSTEROID; DAPSONE; DICLOFENAC; DOXYCYCLINE; DURAFLOR; FLUORIDE; FLUORIDE VARNISH; GROWTH FACTOR; IMMUNOSUPPRESSIVE AGENT; METHOTREXATE; METRONIDAZOLE; MINOCYCLINE; MONOMER; NONSTEROID ANTIINFLAMMATORY AGENT; PENCICLOVIR; PERIOCHIP; PERIOCLINE; POTASSIUM NITRATE; STANNOUS FLUORIDE; TETRACYCLINE; TRIAMCINOLONE ACETONIDE; UNINDEXED DRUG;

ADRENAL SUPPRESSION; APHTHOUS STOMATITIS; BONE GRAFT; CLINICAL TRIAL; DENTAL CARE; DENTAL CARIES; DENTIN SENSITIVITY; DRUG DELIVERY SYSTEM; DRUG FORMULATION; DRUG RELEASE; ENCAPSULATION; HERPES; HUMAN; MOUTH DISEASE; MUCOSA INFLAMMATION; ORAL MUCOSAL DISEASE; OSTEOLYSIS; PERIODONTITIS; PRIMARY PREVENTION; PRIORITY JOURNAL; REVIEW; SIDE EFFECT; SUSTAINED RELEASE FORMULATION;

BONE AND BONES; DRUG DELIVERY SYSTEMS; HUMANS; MOUTH DISEASES; PHARMACEUTICAL PREPARATIONS; TOOTH DISEASES;

EID: 33750124737     PISSN: 1061186X     EISSN: 10292330     Source Type: Journal    
DOI: 10.1080/10611860600834433     Document Type: Review

References (88)

1. About.com [Internet]. 2006. Top 10 Cold Sore Treatment and Prevention Products, [Cited 2006 April 10]. Available from: http://healing.about.com/od/acne/tp/coldsorepicks.htm
2. Addy, M. (1990) Etiology and clinical implications of dentine hypersensitivity Dent Clin North Am, 34, pp. 503-514.
3. American Academy of Periodontology. (2003) Oral features of mucocutaneous disorders: Position paper J Periodontol, 74, pp. 1545-1556.
4. Bawden, JW. (1998) Fluoride varnish: A useful new tool for public health dentistry J Public Health Dent, 58, pp. 266-269.
5. Beekman, B and Drijfhout, JW and Bloemhoff, W and Ronday, HK and Tak, PP and te Koppele, JM. (1996) Convenient fluorometric assay for matrix metalloproteinase activity and its application in biological media FEBS Lett, 390, pp. 221-225.
6. Berg, JH. (2002) Glass ionomer cements Pediatr Dent, 24, pp. 430-438.
7. Borrell, LN and Burt, BA and Gillespie, BW and Lynch, J and Neighbors, H. (2002) Periodontitis in the United States: Beyond black and white J Public Health Dent, 62, pp. 92-101.
8. Camargo, PM and Lekovic, V and Weinlaender, M and Vasilic, N and Madzarevic, M and Kenney, EB. (2005) A reentry study on the use of bovine porous bone mineral, GTR, and platlet-rich plasma in the regenerative treatment of intrabony defects in humans Int J Periodontics Restorative Dent, 25, pp. 49-59.
9. Castillo, JL and Milgrom, P and Kharasch, E and Izutsu, K and Fey, M. (2001) Evaluation of fluoride release from commercially available fluoride varnishes J Am Dent Assoc, 132, pp. 1389-1392.
10. Castillo, JL and Milgrom, P. (2004) Fluoride release from varnishes in two in vitro protocols J Am Dent Assoc, 135, pp. 1696-1699.
11. Chaussain-Miller, C and Fioretti, F and Goldberg, M and Menashi, S. (2006) The role of matrix metalloproteinases (MMPs) in human caries J Dent Res, 85, pp. 22-32.
12. Clarkson, JE and Worthington, HV and Eden, OB. (2004) Interventions for preventing oral mucositis for patients with cancer receiving treatment Cochrane Database Syst Rev (3), pp. CD000978.
13. Corsair, A. (1994) Long-term effect of tetracycline fibers on recurrent lesions in periodontal maintenance patients Periodontal Clin Investig, 16, pp. 8-13.
14. Cote, S and Geltman, P and Nunn, M and Lituri, K and Henshaw, M and Garcia, RI. (2004) Dental caries of refugee children compared with U.S. children Pediatrics, 114, pp. 733-740.
15. Croll, TP and Nicholson, JW. (2002) Glass ionomer cements in pediatric dentistry: Review of the literature Pediatr Dent, 24, pp. 423-429.
16. De Bruyne, MA and De Moor, RJ. (2004) The use of glass ionomer cements in both conventional and surgical endodontics Int Endod J, 37, pp. 91-104.
17. Deng, DM and van Loveren, C and ten Cate, JM. (2005) Caries-preventive agents induce remineralization of dentin in a biofilm model Caries Res, 39, pp. 216-223.
18. Denny, WA. (2004) Prospects for hypoxia-activated anticancer drugs Curr Med Chem Anti-canc Agents, 4, pp. 395-399.
19. Dexcel Pharma 2006 [Internet]. Periochip for treatment of inflamed periodontal pockets, [Cited 2006 April 10]. Available from: Http://www.periochip.com
20. Dodd, MJ and Facione, NC and Dibble, SL and MacPhail, L. (1996) Comparison of methods to determine the prevalence and nature of oral mucositis Cancer Pract, 4, pp. 312-318.
21. Dori, F and Arweiler, N and Gera, I and Sculean, A. (2005) Clinical evaluation of an enamel matrix protein derivative combined with either a natural bone mineral or β-tricalcium phosphate J Periodontol, 76, pp. 2236-2243.
22. Drug information online [Internet]. Revised 1999 June 11 - [Cited 2006 April 10]. Available from: http://www.drugs.com/cons/actisite.html 1999.
23. Engelbrecht J. 2003. Adhesive fluoride varnish, US 2003/0183124.
24. Etrych, T and Jelinkova, M and Rihova, B and Ulbrich, K. (2001) New HPMA copolymers containing doxorubicin bound via pH-sensitive linkage: Synthesis and preliminary in vitro and in vivo biological properties J Control Release, 73, pp. 89-102.
25. Featherstone, JDB and Ten Cate, JM.(1988) Physicochemical aspects of fluoride-enamel interactions. In Fluoride in dentistry. (pp. 125-149). Copenhagen: Munksgaard.
26. Forsten, L. (1998) Fluoride release and uptake by glass ionomers and related materials and its clinical effect Biomaterials, 19, pp. 503-508.
27. Fridman, M and Steinberg, D. (1990) Sustained-release delivery systems for treatment of dental diseases Pharm Res, 7, pp. 313-317.
28. Fujisaki, J and Tokunaga, Y and Takahashi, T and Kimura, S and Shimojo, F and Hata, T. (1997) Osteotropic drug delivery system (ODDS) based on bisphosphonic prodrug. V. Biological disposition and targeting characteristics of osteotropic estradiol Biol Pharm Bull, 20, pp. 1183-1187.
29. Garrett, S and Adams, DF and Bogle, G and Donly, K and Drisko, CH and Hallmon, WW and (2000) The effect of locally delivered controlled-release doxycycline or scaling and root planing on periodontal maintenance patients over 9 months J Periodontol, 71, pp. 22-30.
30. Gittens, SA and Bansal, G and Zernicke, RF and Uludag, H. (2005) Designing proteins for bone targeting Adv Drug Deliv Rev, 57, pp. 1011-1036.
31. Greer, RO, Jr. and Lindenmuth, JE and Juarez, T and Khandwala, A. (1993) A double-blind study of topically applied 5% amlexanox in the treatment of aphthous ulcers J Oral Maxillofac Surg, 51, pp. 243-248.
32. Holbrook, WP and Kristmundsdottir, T and Loftsson, T. (1998) Aqueous hydrocortisone mouthwash solution: Clinical evaluation Acta Odontol Scand, 1998(56), pp. 157-160.
33. Jensen, OE and Bilings, RJ and Featherstone, JD. (1990) Clinical evaluation of fluroshield pit and fissure sealant Clin Prev Dent, 12, pp. 24-27.
34. Jung, RE and Glauser, R and Scharer, P and Hammerle, CH and Sailer, HF and Weber, FE. (2003) Effect of rhBMP-2 on guided bone regeneration in humans Clin Oral Implants Res, 14, pp. 556-568.
35. Jurge, S and Kuffer, R and Scully, C and Porter, SR. (2006) Mucosal disease series. Number VI. Recurrent aphthous stomatitis Oral Dis, 12, pp. 1-21.
36. Kasugai, S and Fujisawa, R and Waki, Y and Miyamoto, K and Ohya, K. (2000) Selective drug delivery system to bone: Small peptide (Asp)6 conjugation J Bone Miner Res, 15, pp. 936-943.
37. Khandwala, A and Van Inwegen, RG and Alfano, MC. (1997) 5% amlexanox oral paste, a new treatment for recurrent minor aphthous ulcers: I. Clinical demonstration of acceleration of healing and resolution of pain Oral Surg Oral Med Oral Pathol Oral Radiol Endod, 83, pp. 222-230.
38. Kidd, EA and Fejerskov, O. (2004) What constitutes dental caries? Histopathology of carious enamel and dentin related to the action of cariogenic biofilms J Dent Res, 83, pp. C35-C38.
39. Killoy, WJ. (1998) The use of locally delivered chlorhexidine in the treatment of periodontitis. Clinical results J Clin Periodontol, 25, pp. 953-958.
40. Kolokotronis, A and Doumas, S. (2006) Herpes simplex virus infection, with particular reference to the progression and complications of primary herpetic gingivostomatitis Clin Microbiol Infect, 12, pp. 202-211.
41. Kopeček, J and Kopečková, P and Minko, T and Lu, Z. (2000) HPMA copolymer-anticancer drug conjugates: Design, activity, and mechanism of action Eur J Pharm Biopharm, 50, pp. 61-81.
42. Kratz, F and Beyer, U and Schutte, MT. (1999) Drug-polymer conjugates containing acid-cleavable bonds Crit Rev Ther Drug Carrier Syst, 16, pp. 245-288.
43. Lalla, RV and Peterson, DE. (2005) Oral mucositis Dent Clin North Am, 49, pp. 167-184.
44. Lin, JH. (1996) Bisphosphonates: A review of their pharmacokinetic properties Bone, 18, pp. 75-85.
45. Lin, L and Chen, XS and Cui, PG and Wang, JB and Guo, ZP and Lu, NZ and (2002) Topical penciclovir clinical study group. Topical application of penciclovir cream for the treatment of herpes simplex facialis/labialis: A randomized, double-blind, multicentre, aciclovir-controlled trial J Dermatolog Treat, 13, pp. 67-72.
46. Marinho, VCC and Higgins, J and Logan, S and Sheiham, A. (2002) Fluoride varnishes for preventing dental caries in children and adolescents Cochrane Database Syst Rev (3), pp. CD002279.
47. Marinho, VCC and Higgins, J and Sheiham, A and Logan, S. (2003a) Fluoride toothpastes for preventing dental caries in children and adolescents Cochrane Database Syst Rev (1), pp. CD002278.
48. Marinho, VCC and Higgins, J and Logan, S and Sheiham, A. (2003b) Fluoride mouth rinses for preventing dental caries in children and adolescents Cochrane Database Syst Rev (3), pp. CD002284.
49. Marinho, VCC and Higgins, J and Logan, S and Sheiham, A. (2003c) Systematic review of controlled trials on the effectiveness of fluoride gels for the prevention of dental caries in children J Dent Educ, 67, pp. 448-458.
50. Marks, SC, Jr. and Miller, SC. (1994) Local delivery of prostaglandin E1 induces periodontal regeneration in adult dogs J Periodontal Res, 29, pp. 103-108.
51. Miller, SC and Marks, SC, Jr. (1993) Local stimulation of new bone formation by prostaglandin E1: Quantitative histomorphometry and comparison of delivery by minipumps and controlled-release pellets Bone, 14, pp. 143-151.
52. Morphis, TL and Toumba, KJ and Lygidakis, NA. (2000) Fluoride pit and fissure sealants: A review Int J Paediatr Dent, 10, pp. 90-98.
53. Morvan, FO and Baroukh, B and Ledoux, D and Caruelle, JP and Barritault, D and Godeau, G and (2004) An engineered biopolymer prevents mucositis induced by 5-fluorouracil in hamsters Am J Pathol, 164, pp. 739-746.
54. Murray, B and McGuinness, N and Biagioni, P and Hyland, P and Lamey, PJ. (2005) A comparative study of the efficacy of aphtheal in the management of recurrent minor aphthous ulceration J Oral Pathol Med, 34, pp. 413-419.
55. Murray, JJ and Rugg-Gunn, AJ and Jenkins, GN.(1991) A history of water fluoridation. In Fluorides in caries prevention. (pp. 7-37). Oxford: Wright.
56. Naidu, MU and Ramana, GV and Rani, PU and Mohan, IK and Suman, A and Roy, P. (2004) Chemotherapy-induced and/or radiation therapy-induced oral mucositis - complicating the treatment of cancer Neoplasia, 6, pp. 423-431.
57. Nakagawa, T and Yamada, S and Oosuka, Y and Saito, A and Hosaka, Y and Ishikawa, T and (1991) Clinical and microbiological study of local minocycline delivery (Periocline) following scaling and root planing in recurrent periodontal pockets Bull Tokyo Dent Coll, 32, pp. 63-70.
58. Nevada State Health Division, Oral Health Program.(2005) Fluoride varnish manual.
59. Nevins, M and Giannobile, WV and McGuire, MK and Kao, RT and Mellonig, JT and Hinrichs, JE and (2005) Platlet-derived growth factor stimulates bone fill and rate of attachement level gain: Results of a large multicenter-randomized controlled trial J Periodontol, 76, pp. 2205-2215.
60. Nisengard, RJ and Rogers, RS, III. (1987) The treatment of desquamative gingival lesions J Periodontol, 58, pp. 167-172.
61. Ogaard, B and Seppa, L and Rolla, G. (1994) Professional topical fluoride applications-clinical efficacy and mechanism of action Adv Dent Res, 8, pp. 190-201.
62. Palmer, RM and Matthews, JP and Wilson, RF. (1998) Adjunctive systemic and locally delivered metronidazole in the treatment of periodontitis: A controlled clinical study Br Dent J, 184, pp. 548-552.
63. Pozo, P and Valenzuela, MA and Melej, C and Zaldivar, M and Puente, J and Martinez, B and (2005) Longitudinal analysis of metalloproteinases, tissue inhibitors of metalloproteinases and clinical parameters in gingival crevicular fluid from periodontitis-affected patients J Periodontal Res, 40, pp. 199-207.
64. Raborn, GW and Grace, MG. (2003) Recurrent herpes simplex labialis: Selected therapeutic options J Can Dent Assoc, 69, pp. 498-503.
65. Rawls, HR. (1991) Preventive dental materials: Sustained delivery of fluoride and other therapeutic agents Adv Dent Res, 5, pp. 50-55.
66. Riep, B and Purucker, P and Bernimoulin, JP. (1999) Repeated local metronidazole-therapy as adjunct to scaling and root planing in maintenance patients J Clin Periodontol, 26, pp. 710-715.
67. Rivera-Hidalgo, F and Shulman, JD and Beach, MM. (2004) The association of tobacco and other factors with recurrent aphthous stomatitis in an U.S. adult population Oral Dis, 10, pp. 335-345.
68. Robinson, NA and Wray, D. (2003) Desquamative gingivitis: A sign of mucocutaneous disorders - a review Aust Dent J, 48, pp. 206-211.
69. Salvi, GE and Williams, RC and Offenbacher, S. (1997) Nonsteroidal anti-inflammatory drugs as adjuncts in the management of periodontal diseases and peri-implantitis Curr Opin Periodontol, 4, pp. 51-58.
70. Saxen, MA and Ambrosius, WT and Rehemtula, al-KF and Russell, AL and Eckert, GJ. (1997) Sustained relief of oral aphthous ulcer pain from topical diclofenac in hyaluronan: A randomized, double-blind clinical trial Oral Surg Oral Med Oral Pathol Oral Radiol Endod, 84, pp. 356-361.
71. Shulman, JD. (2004) Recurrent herpes labialis in U.S. children and youth Community Dent Oral Epidemiol, 32, pp. 402-409.
72. Sirois, D and Leigh, JE and Sollecito, TP. (2000) Oral pemphigus vulgaris preceding cutaneous lesions: Recognition and diagnosis J Am Dent Assoc, 131, pp. 1156-1160.
73. Sorsa, T and Tjaderhane, L and Salo, T. (2004) Matrix metalloproteinases (MMPs) in oral diseases Oral Dis, 10, pp. 311-318.
74. Spruance, SL and Nett, R and Marbury, T and Wolff, R and Johnson, J and Spaulding, T. (2002) Acyclovir cream for treatment of herpes simplex labialis: Results of two randomized, double-blind, vehicle-controlled, multicenter clinical trials Antimicrob Agents Chemother, 46, pp. 2238-2243.
75. Stein, D and Lee, Y and Schmid, MJ and Killpack, B and Genrich, MA and Narayana, N and (2005) Local simvastatin effects on mandibular bone growth and inflammation J Periodontol, 76, pp. 1861-1870.
76. Ten Cate, JM. (1999) Current concepts on the theories of the mechanism of action of fluoride Acta Odontol Scand, 57, pp. 325-329.
77. Terada, T and Iwai, M and Kawakami, S and Yamashita, F and Hashida, M. (2006) Novel PEG-matrix metalloproteinase-2 cleavable peptide-lipid containing galactosylated liposomes for hepatocellular carcinoma-selective targeting J Control Release, 111, pp. 333-342.
78. Tjaderhane, L and Larjava, H and Sorsa, T and Uitto, VJ and Larmas, M and Salo, T. (1998) The activation and function of host matrix metalloproteinases in dentin matrix breakdown in caries lesions J Dent Res, 77, pp. 1622-1629.
79. Turk, BE and Lee, DH and Yamakoshi, Y and Klingenhoff, A and Reichenberger, E and Wright, JT and (2006) MMP-20 is predominately a tooth-specific enzyme with a deep catalytic pocket that hydrolyzes type V collagen Biochemistry, 45, pp. 3863-3874.
80. United States Department of Health Human Services [Internet]. 2000. Oral health in America: A report of the surgeon general, [Cited 2006 April 10]. Available from: http://www.surgeongeneral.gov/library/oralhealth/
81. Walters, PA. (2005) Dentinal hypersensitivity: A review J Contemp Dent Pract, 6, pp. 107-117.
82. Wang, D and Miller, S and Sima, M and Kopečková, P and Kopećek, J. (2003) Synthesis and evaluation of water-soluble polymeric bone-targeted drug delivery systems Bioconjug Chem, 14, pp. 853-859.
83. Wang, D and Miller, SC and Kopečková, P and Kopeček, J. (2005) Bone-targeting macromolecular therapeutics Adv Drug Deliv Rev, 57, pp. 1049-1076.
84. Williams, C.(1984) Radiopharmaceuticals in bone scanning. In Bone scintigraphy. (pp. 13-38). New York: Futura Publishing Company.
85. Williams, D and Meier, P and Gron, P and Mullins, TJ and Hitchcock, CC and Bowen, WH. (1982) Cariostatic microcapsules for aerosol delivery J Pedod, 6, pp. 218-228.
86. Williams, RC and Paquette, DW and Offenbacher, S and Adams, DF and Armitage, GC and Bray, K and (2001) Treatment of periodontitis by local administration of minocycline microspheres: A controlled trial J Periodontol, 72, pp. 1535-1544.
87. Yokogawa, K and Miya, K and Sekido, T and Higashi, Y and Nomura, M and Fujisawa, R and (2001) Selective delivery of estradiol to bone by aspartic acid oligopeptide and its effects on ovariectomized mice Endocrinology, 42, pp. 1228-1233.
88. Yum, SI and Yum, E.(2005) Drug delivery systems for the treatment of periodontal and dental diseases. In Drug delivery to the oral cavity: Molecules to market. (pp. 211-232). Florida, FL: CRC press.